Quantitative MR spectroscopic imaging of brain lesions in patients with AIDS: Correlation with [11C-methyl]thymidine pet and thallium-201 SPECT

Academic Radiology

Volumn 9, Issue 4, 2002, Pages 398-409

  Pomper, Martin G ^a   Constantinides, Chris D ^b   Barker, Peter B ^a   Bizzi, Alberto ^a   Dobgan, A Semih ^a   Yokoi, Fuji ^a   McArthur, Justin C ^a,c   Wong, Dean F ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Johns Hopkins University   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Acquired immunodeficiency syndrome (AIDS); Lymphoma; Magnetic resonance (MR) spectroscopic imaging; Positron emission tomography (PET); Single positron emission computed tomography (SPECT); Toxoplasmosis

Indexed keywords

CARBON 11; GADOLINIUM PENTETATE; THALLIUM 201; THYMIDINE DERIVATIVE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BRAIN INJURY; BRAIN LYMPHOMA; CLINICAL ARTICLE; CORRELATION FUNCTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RELIABILITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TOXOPLASMOSIS;

EID: 0036128908     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1076-6332(03)80185-X     Document Type: Article

References (57)

1. Cerebral toxoplasmosis and lymphoma in AIDS: Perfusion MR imaging experience in 13 patients
2. Primary central nervous system lymphoma: Radiologic-pathologic correlation
3. Metabolite abnormalities in progressive multifocal leukoencephalopathy by proton magnetic resonance spectroscopy
4. HIV-associated primary CNS morbidity and utility of brain biopsy
5. The variable MR appearance of primary lymphoma of the central nervous system: Comparison with histopathologic features
6. Diagnostic imaging of the brain in acquired immunodeficiency syndrome (AIDS)
7. Thallium-201 accumulation in cerebral candidiasis: Unexpected finding on SPECT
8. Central nervous system lymphoma not detectable on single-photon emission CT with thallium-201
9. Evaluating contrast-enhancing brain lesions in patients with AIDS by using positron emission tomography
10. Differentiation of central nervous system lesions in AIDS patients using positron emission tomography (PET)
11. Toxoplasmosis and primary central nervous system lymphoma in HIV infection: Diagnosis with MR spectroscopy
12. Brain lesions in patients with AIDS: H-1 MR spectroscopy
13. A multiparametric data analysis showing the potential of localized proton MR spectroscopy of the brain in metabolic characterization of neurological diseases
14. In vivo proton spectroscopy of intracranial infections and neoplasms
15. Localized 1H-MR spectroscopy for metabolic characterization of diffuse and focal brain lesions in patients infected with HIV
16. Progressive multifocal leukoencephalopathy and human immunodeficiency virus-associated white matter lesions in AIDS: Magnetization transfer MR imaging
17. AIDS dementia complex: Evaluation with proton MR spectroscopic imaging
18. Multisection proton MR spectroscopic imaging of the brain
19. Quantitative proton MR spectroscopic imaging of the human brain
20. 11C]thymidine
21. High performance liquid chromatography of carbon-11 labeled thymidine and its major catabolites for clinical PET studies
22. [Methyl-carbon-11]thymidine for in vivo measurement of cell proliferation
23. Carbon-11-thymidine and FDG to measure therapy response
24. Brain tumor imaging with PET and 2-[carbon-11]thymidine
25. 11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography
26. An algorithm for least squares estimation on nonlinear parameters
27. Changing disease paterns in focal brain lesion-causing disorders in AIDS
28. MR spectroscopy and diffusion-weighted MR imaging in focal brain lesions in AIDS
29. Neuroimaging findings in patients with AIDS
30. Clinical applications of magnetic resonance spectroscopy
31. Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: Initial experience in patients with cerebral tumors
32. Brain abscess and brain tumor: Discrimination with in vivo H-1 MR spectroscopy
33. Neurological complications of HIV infection
34. In vivo magnetic resonance spectroscopy in HIV and HIV-related brain diseases
35. Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex
36. The proton NMR spectrum in acute EAE: The significance of the change in the Cho:Cr ratio
37. Proton magnetic resonance spectroscopy in multiple sclerosis
38. Hemorrhagic presentation of untreated primary CNS lymphoma in a patient with AIDS
39. Neuronal loss in the frontal cortex in HIV infection
40. Proton magnetic resonance spectroscopy in patients with glial tumors: A multicenter study
41. Proton magnetic resonance spectroscopy pattern of progressive multifocal leukoencephalopathy in AIDS
42. Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy
43. FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS
44. Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake
45. [Methyl-carbon-11]thymidine positron emission tomography in tumoral and non-tumoral cerebral lesions
46. Sensitivity and specificity of thallium-201 single-photon emission tomography in the functional detection and differential diagnosis of brain tumors
47. 201TI single-photon emission computed tomography
48. Rapid differential diagnosis of cerebral toxoplasmosis and primary central nervous system lymphoma by thallium-201 SPECT
49. Thallium-201 brain SPECT of lymphoma in AIDS patients: Pitfalls and technique optimization
50. Thallium-201 retention in focal intracranial lesions for differential diagnosis of primary lymphoma and nonmalignant lesions in AIDS patients
51. Brain tumor imaging with C-II labeled thymidine and PET
52. TI-201 chloride and Tc-99m ECD brain SPECT in lymphoma with and without massive necrosis
53. 99Tcm-sestamibi SPET brain imaging for differentiating intracranial lymphoma from non-malignant lesions in AIDS patients
54. Pre-clinical studies of 2′fluoro-5-[C-11]methyl-β-D-arabinofuranosyluracil (FMAU): A potential PET indicator of tumor proliferation
55. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography
56. Value of combined approach with thallium-201 single-photon emission computed tomography and Epstein-Barr virus DNA polymerase chain reaction in cerebrospinal fluid for the diagnosis of AIDS-related primary CNS lymphoma
57. Intracranial mass lesions: Sequenial thallium and gallium scintigraphy in patients with AIDS